• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

Transgene

  • ID: 630659
  • April 2015
  • 56 Pages
  • Wright Investors Service

A textual analysis of the financial results for Transgene compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business description of the company, including contact information, senior officers and Wright Quality Rating analyses is also provided.

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio tables (Accounting, Asset Utilization, Employee Efficiency, Fixed Charges Coverage, Leverage Analysis, Liquidity Analysis, Per-share Data and Profitability Analysis) and proprietary Wright Quality Rating analyses tables. The Wright Quality Rating, a measure of corporate risk, examines the liquidity of the stock, financial strength, profitability and corporate growth characteristics of Transgene. There is a textual review of the financial results of Transgene and three of its industry peers. . The comparative analysis of these companies compares Sales (sales, sales growth and sales per employee), Company Valuations (Price/Earnings, Price/Book, Price/Sales and 52-Week Price Change) and Financial Position (Long-term Debt/Equity). Also included for Transgene are the Company Description, Recent Stock Performance, Profitability Analysis, Dividend Analysis, and Key Data Items (Ticker, Major Industry, Sub-Industry, Fiscal Year End Month, Employees, Share Type, Market Capitalization, Total Shares Outstanding and Number of Closely Held Shares.) Additional research for Transgene includes tables with up to 10-years of history of computed ratios, sales, earnings, and security prices.

Note: Product cover images may vary from those shown

Company Fundamentals
- Company Profile
- Comparative Business Analysis
- Summary Analysis per Share
- Sales Analysis
- Price Analysis
- Earnings and Dividends Analysis

Financial Statement Analyses
- Balance Sheet - Common Size
- Balance Sheet - Year-Year Percent Change
- Balance Sheet - Five-Year Averages
- Income Statement - Common Size
- Income Statement - Year-Year Percent Change
- Income Statement - Five-Year Averages
- Sources of Capital

Financial Ratio Analyses
- Accounting Ratios
- Asset Utilization
- Employee Efficiency
- Fixed Charges Coverage
- Leverage Analysis
- Liquidity Analysis
- Per-Share Data
- Profitability Analysis

Wright Quality Rating Analyses
- Investment Acceptance
- Financial Strength
- Profitability and Stability
- Corporate Growth

Note: Product cover images may vary from those shown

Linkmed AB, Omega Diagnostics Group Plc and Navamedic ASA

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

  • Transgene SA - Product Pipeline Review - 2012 - Product Thumbnail Image Transgene SA - Product Pipeline Review - 2012
    FROM
  • Transgene SA - Product Pipeline Review - 2013 - Product Thumbnail Image

    Transgene SA - Product Pipeline Review - 2013

    • Language: English
    • Published: July 2013
    FROM
  • Mavens Biotech Limited - Product Thumbnail Image

    Mavens Biotech Limited

    • Language: English
    • 54 Pages
    • Published: April 2015
    FROM
  • Saamya Biotech (India) Limited - Product Thumbnail Image

    Saamya Biotech (India) Limited

    • Language: English
    • 54 Pages
    • Published: April 2015
    • Region: India
    FROM
  • Navamedic ASA - Product Thumbnail Image

    Navamedic ASA

    • Language: English
    • 55 Pages
    • Published: March 2015
    FROM
  • Piramal Phytocare Ltd - Product Thumbnail Image

    Piramal Phytocare Ltd

    • Language: English
    • 55 Pages
    • Published: April 2015
    FROM
  • Transgene Biotek Limited - Product Thumbnail Image

    Transgene Biotek Limited

    • Language: English
    • 54 Pages
    • Published: April 2015
    FROM
  • Innate Pharma S.A. - Product Thumbnail Image

    Innate Pharma S.A.

    • Language: English
    • 56 Pages
    • Published: April 2015
    FROM
  • Telefonica SA - Product Thumbnail Image

    Telefonica SA

    • Language: English
    • 57 Pages
    • Published: April 2015
    FROM
  • Nicox SA - Product Thumbnail Image

    Nicox SA

    • Language: English
    • 56 Pages
    • Published: April 2015
    FROM

Our Clients

Fluidigm Corporation Apple, Inc. CEVA Santé Animale Abbott Laboratories Ltd. Merck Group Allergan Inc. Pfizer, Inc.